From evidence to action: Understanding clinical practice guidelines by Poolman, Rudolf W et al.
Acta Orthopaedica 2009; 80 (1): 113–118  113
From evidence to action
Understanding clinical practice guidelines
Rudolf W Poolman1, Cees CPM Verheyen2, Gino M Kerkhoffs3, Mohit Bhandari4, and     
Holger J Schünemann5
On behalf of the International Evidence-Based Orthopedic Surgery Working Group
1Department of Orthopedic Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam; 2Department of Orthopaedic Surgery, Isala Klinieken, Zwolle; 3Department 
of Orthopedic Surgery, Orthotrauma Research Center, Academic Medical Center, University of Amsterdam, the Netherlands; 4Division of Orthopedic 
Surgery, McMaster University, Ontario, Canada; 5Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy
Correspondence RWP: ieboswg@gmail.com  
Submitted 08-10-28. Accepted 08-11-29
Copyright © Informa Healthcare Ltd 2009. ISSN 1745–3674. Printed in Sweden – all rights reserved.
DOI  10.1080/17453670902807458
ABSTRACT   Good guidelines will help us to take evidence into 
practice. In a survey among Dutch orthopedic surgeons, develop-
ment and use of evidence-based guidelines was perceived as one 
of the best ways of moving from opinion-based to evidence-based 
orthopedic practice. The increasing number of guidelines means 
that knowing how to make a critical appraisal of guidelines is now 
a key part of every surgeon’s life. This is particularly true because 
guidelines use varying systems to judge the quality of evidence 
and  the  strength  of  recommendations.  In  this  manuscript  we 
discuss what a guideline is, where we can find guidelines, how to 
evaluate the quality of guidelines, and finally provide an example 
on the different steps of guideline development. Thus, we show 
that good guidelines are a summary of the best available evidence 
and that they provide a graded recommendation to help surgeons 
in evidence-based practice.

In the post-Second World War era, surgeons used a wide vari-
ety of treatment modalities for comparable conditions. The 
decisions for or against a certain treatment option were pri-
marily based on the origin of the doctor’s training, and less fre-
quently based on sound research findings (Mooij 1999). This 
inter-doctor variability was recognized by medical organiza-
tions and subsequently consensus meetings were conducted 
to develop clinical guidelines (Mooij 1999). Initially based 
on expert opinions without explicit evaluation of the available 
evidence, these consensus meetings later started to implement 
research findings in the consensus process (Mooij 1999). 
Good guidelines will help us to take evidence into practice. 
In a survey among Dutch orthopedic surgeons, the develop-
ment and use of evidence-based guidelines was perceived as 
one of the best ways to move from opinion-based to evidence-
based orthopedic practice (Poolman et al. 2007b). However, 
the number of guidelines is increasing. For example, a search 
in  the  National  Guideline  Clearinghouse  for  guidelines  on 
knee arthritis revealed 34 hits; a search on hip fracture guide-
lines resulted in 57 hits. This increasing number of guidelines 
requires that knowledge of how to make a critical appraisal 
of guidelines is now becoming a key part of every surgeon’s 
life. This is particularly true because guidelines use varying 
systems to judge the quality of evidence and the strength of 
recommendations.  An  increasing  number  of  organizations 
have come to an agreement to use a common system for for-
mulation of recommendations in guidelines. This system, the 
GRADE  system,  suggests  that  recommendations  given  in 
guidelines can be either strong or weak (Guyatt et al. 2008a). 
The quality of the underlying evidence is one of the factors 
that determines the strength of a recommendation. Thus, good 
guidelines summarize the best available evidence and provide 
a graded recommendation to help surgeons in evidence-based 
practice. 
In this article, we provide principles of guideline develop-
ment, and databases of guidelines, and we give a case example 
of the development of a recently developed set of guidelines.
What are guidelines? 
Guidelines are devised to help doctors in the clinical deci-
sion process. They should include a clear recommendation for 
action (Oxman et al. 2006, Guyatt et al. 2008a). In contrast to 
guidelines, systematic reviews provide no recommendations. 
Recommending a treatment is a key feature of a guideline. 
Guidelines are often mistaken for cookbooks; however, guide-
line is not just another word for law or rule. Although both 
should be followed and both can be acted upon, guidelines are 
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likely to have exceptions in certain circumstances—depending 
on the strength of the recommendations. Furthermore, guide-
lines should be used as a resource. That is, relevant questions 
should be answered in a set of guidelines and not all recom-
mendations necessarily apply to all patients. Any document is 
considered a guideline when it aims to streamline particular 
processes according to a set routine. By definition, following 
guidelines is never mandatory. A protocol would be a better 
term  for  a  mandatory  procedure.  Guidelines  can  facilitate 
higher quality and predictability of action of healthcare work-
ers. 
In  past  centuries,  consensus  in  medical  decision  making 
was  reached  through  eminence-based  strategies.  Decision 
making was highly influenced by the simple fact that if an 
eminent professor stated something as a golden rule or a good 
idea, or guideline, then it was considered a guideline. The 
modern guideline-based approach to healthcare originated in 
the 1990s. In the Netherlands, guidelines are produced at the 
national level by medical associations. Two bodies, CBO (the 
Dutch Institute for Healthcare Improvement) and NHG (the 
Dutch College of General Practitioners) publish specialist and 
primary care guidelines, respectively. 
Internationally,  there  has  been  progress  in  the  develop-
ment of guideline. Modern medical guidelines are documents 
designed  to  guide  decisions  and  criteria  in  specific  medi-
cal areas, as defined by the best research evidence available 
(Guyatt et al. 2008a). Clinical guidelines identify and evaluate 
the most current data about prevention, diagnosis and/or treat-
ment, eventually including the dosage of medications, risk/
benefit, and cost-effectiveness. Subsequently, these define the 
most important questions related to clinical practice and iden-
tify all possible decision options and their outcomes. Some 
guidelines contain decision algorithms to be followed. Other 
guidelines place the treatment alternatives into classes to help 
providers in deciding what treatment to use. An additional 
objective of a medical guideline is to achieve the best balance 
between cost and effectiveness; it has frequently been dem-
onstrated that the use of guidelines in hospitals is an effective 
way to achieve best practice objectives (Goossens 2004).
How can we find guidelines?
You can find many guideline resources on the internet. We 
suggest  that  one  should  start  by  searching  for  guidelines 
developed in one’s own country, as they are most suitable 
for local circumstances. Institutional guidelines are adjusted 
to the local situation, and are usually adapted from a profes-
sional organization’s guidelines or national guidelines. The 
National Guideline Clearinghouse (NGC) is a public resource 
for evidence-based clinical practice guidelines (http://www.
guideline.gov/). It provides guidelines from several institu-
tions, professional societies, and government agencies world-
wide. A helpful feature is side-by-side comparison of guide-
lines. Another useful source is http://www.guidelines-interna-
tional.net/. Furthermore, the TRIP database can be searched 
for  EBM  guidelines  (http://www.tripdatabase.com/).  In  the 
UK, the National Institute for Health and Clinical Excellence 
(NICE) is the independent organization dedicated to guideline 
development  (http://www.nice.org.uk/).  Finally,  the  G-I-N 
(Guidelines International Network) created the International 
Guideline Library, which includes the International Guideline 
Database with over 5,000 guidelines. G-I-N is a global non-
profit association of organizations and individuals involved 
in the development and use of clinical practice guidelines. It 
aims to improve the quality of healthcare by endorsing the 
systematic  development  of  clinical  practice  guidelines  and 
their application in practice, through worldwide collaboration 
(http://www.g-i-n.net).
How can we evaluate the quality of guidelines? 
The Grading of Recommendations Assessment, Development, 
and Evaluation (GRADE) approach is used by an increasing 
number of other organizations internationally (Schunemann 
et al. 2006b, Guyatt et al. 2008a, Guyatt et al. 2008b). In 
international meetings for over 8 years, the GRADE Working 
Group has developed a set of evidence-based criteria to grade 
the quality of evidence (Table 1) and the strength of recom-
mendations (Table 2) (Schunemann et al. 2006b, Guyatt et al. 
2008a). The GRADE system has several advantages over other 
systems, including explicit definitions and sequential judg-
ments during the grading process; a detailed description of the 
criteria for the quality of evidence for single patient-important 
outcomes and for the overall quality of the evidence; weigh-
ing of the relative importance of outcomes; consideration of 
Table 1. Evidence-based criteria to grade the quality of evidence 
(Schunemann et al. 2006b)
 
Quality of  Study design  Lower if a  Higher if a
evidence
High (4)  Randomized   Study limitations  Large effect
  trial  – 1 serious  + 1 large
    – 2 very serious  + 2 very large
Moderate (3)    Inconsistency  Dose response
    – 1 serious  + 1 evidence of
    – 2 very serious      a gradient
Low (2)  Observational   Indirectness  All plausible
  study  – 1 serious  confounding
    – 2 very serious  + 1 would reduce
         a demonstrated
Very low (1)    Imprecision     effect, or
    – 1 serious  + 2 would suggest
    – 2 very serious     a spurious effect
         when results
    Publication bias     show no effect
    – 1 likely
    – 2 very likely
a 1 = move up or down one grade (for example from high to inter-
mediate) 2 = move up or down two grades (for example from high to 
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the balance between health benefits and harm, burdens, and 
cost; and the development of evidence profiles and summaries 
of findings. In addition, the GRADE group is supported by an 
international collaboration. The main limitation and criticism 
of the GRADE system is its complexity, but this degree of 
complexity is required to provide the necessary transparency 
in guideline development.
The AGREE  (Appraisal  of  Guidelines  for  Research  and 
Evaluation)  collaboration  (http://www.agreecollaboration.
org/) endeavors to establish a shared framework for guideline 
development, reporting, and assessment. An instrument for 
the appraisal of clinical guidelines was developed through this 
collaboration  (AGREE  Collaboration,  2003).  The  AGREE 
instrument can be downloaded from the website and consists 
of six domains: (1) Scope and purpose deals with the overall 
aim of the guideline, the specific clinical questions, and the 
target patient population. (2) Stakeholder involvement focuses 
on the extent to which the guideline represents the views of its 
intended users. (3) Rigor of development relates to the pro-
cess used to gather and synthesize the evidence, the methods 
to formulate the recommendations, and those to update them. 
(4) Clarity and presentation deals with the language and the 
format of the guideline. (5) Applicability pertains to the likely 
organizational, behavioral, and cost implications of applying 
the guideline. (6) Lastly, editorial independence is concerned 
with the independence of the recommendations and acknowl-
edgement of possible conflicts of interests from the guideline 
development group (http://www.agreecollaboration.org/). 
The  Conference  on  Guideline  Standardization  (COGS) 
used a 2-stage modified Delphi process to develop standards 
for reporting clinical practice guidelines, which resulted in the 
COGS checklist (Table 3) (Shiffman et al. 2003, Oxman et al. 
2006) (see http://gem.med.yale.edu/cogs/welcome.do). While 
many associations have their own typical formats for report-
ing guidelines, the COGS checklist is the only agreed standard 
for reporting guidelines between organizations (Oxman et al. 
2006).
Using guidelines to guide practice: a case example of 
guideline development
In the Netherlands, the organization facilitating the develop-
ment of medical guidelines is CBO (the Dutch Institute for 
Healthcare  Improvement),  which  is  financed  by  the  Order 
of Medical Specialists in collaboration with the Dutch Col-
lege of General Practitioners. Since it was founded in 1979, 
more than 125 national guidelines have been published. The 
understanding is that every guideline should be revised after 
5 years. The last Dutch guidelines “Deep Venous Thrombosis 
and Pulmonary Embolism” were published in 1999 and are 
due for revision, entitled “Diagnosis, Prevention and Treat-
ment of Venous Thromboembolism and secondary prevention 
of Arterial Thrombosis”.
For  the  development  of  evidence-based  guidelines,  a 
sequence of steps were taken as illustrated in the Figure.
Lack of high-quality evidence
Certain topics of the subject were ambiguous in the last guide-
lines because of lack of high-quality evidence or confusing 
recommendations. One example was the use of pharmacologi-
cal thromboprophylaxis in daycare surgery (knee arthroscopy) 
or  during  plaster  immobilization.  Also,  relevant  questions 
from the professionals in the field had to be addressed. 
When evidence is of low quality, recommendations will be 
weak. To make recommendations, a consensus will always 
have to be reached. Well-known methods for reaching a con-
sensus are the Nominal Group Technique (NGT), the Delphi 
Method, and Consensus Conferences (Fretheim et al. 2006b).
Fundamental questions and outline of text
Listings  of  major  questions  and  dilemmas  on  the  subject 
derived from the analysis of impediments were assembled. 
Also, a short set-up with planned chapters was proposed. 
Guidelines can be helpful in clinical decision making, pro-
vided that they have been developed following rigorous meth-
odology and provided that they address clinically and patient-
important endpoints (Guyatt et al. 2008b). Thus, a guideline 
must start with a clearly focused clinical question. To identify 
endpoints that are important for patients, consumers (patients) 
can be made part of a consensus group. Consumer values may 
influence  recommendations;  thus,  these  recommendations 
should be marked as such in the final guidelines (Schunemann 
et al. 2006a).
Table 2. Determinants of strength of recommendation (Schunemann et al. 2006b)
Factors that can strengthen the strength  Comment
of a recommendation  
Balance between desirable and   The larger the difference between the desirable and undesirable consequences, the more likely  
undesirable effects  a strong recommendation is warranted. The smaller the net benefit and the lower the certainty    
    for that benefit, the more likely weak recommendations are warranted.
Quality of the evidence   The higher the quality of evidence, the more likely a strong recommendation.
Values and preferences   The greater the variability in values and preferences, or uncertainty in values and preferences,    
    the more likely a weak recommendation is warranted.
Costs (resource allocation)   The higher the costs of an intervention—that is, the more resources consumed— the less likely    
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Table 3. The COGS checklist for reporting clinical practice guidelines (Shiffman et al. 2003) a
Topic   Description
1.   Overview material  Provide a structured abstract that includes the guideline’s release date, status (original, revised, updated), and print    
  and electronic sources.
2.   Focus   Describe the primary disease/condition and intervention/service/technology that the guideline addresses. Indicate any  
  alternative preventive, diagnostic, or therapeutic interventions that were considered during development.
3.   Goal   Describe the goal that following the guideline is expected to achieve, including the rationale for development of a    
  guideline on this topic.
4.   Users/setting   Describe the intended users of the guideline (e.g., provider types, patients) and the settings in which the guideline is   
  intended to be used.
5.   Target population   Describe the patient population eligible for guideline recommendations and list any exclusion criteria.
6.   Developer   Identify the organization(s) responsible for development of the guideline and the names/credentials/potential conflicts    
  of interest of individuals involved in the development.
7.   Funding    Identify the funding source/sponsor and describe its role in developing and/or reporting the guideline. Disclose poten   
      sources/sponsor  tial conflicts of interests.
8.   Evidence collection  Describe the methods used to search the scientific literature, including the range of dates and databases searched,    
  and criteria applied to filter the evidence retrieved.
9.   Recommendation    Describe the criteria used to rate the quality of evidence that supports the recommendations, and the system for    
      grading criteria  describing the strength of the recommendations. Recommendation strength communicates the importance of    
  adherence to a recommendation and is based on both the quality of the evidence and the magnitude of anticipated    
  benefits or harm.
10. Method for synthe-   Describe how evidence was used to create recommendations, e.g., evidence tables, meta-analysis, decision analysis.
      sizing evidence
11. Prerelease review   Describe how the guideline developer reviewed and/or tested the guidelines prior to release.
12. Update plan   State whether or not there is a plan to update the guideline and, if applicable, an expiration date for this version of the  
  guideline.
13. Definitions   Define unfamiliar terms, and those that are critical to correct application of the guideline and that might be subject to   
  misinterpretation.
14. Recommendations   State the recommended action precisely and the specific circumstances under which to perform it. Justify each    
      and rationale  recommendation by describing the linkage between the recommendation and its supporting evidence. Indicate    
  the quality of evidence and the strength of recommendation, based on the criteria described in 9.
15. Potential benefits    Describe anticipated benefits and potential risks associated with implementation of guideline recommendations.
      and harm
16. Patient preferences  Describe the role of patient preferences when a recommendation involves a substantial element of personal choice or 
  values.
17. Algorithm   Provide (where appropriate) a graphical description of the stages and decisions in clinical care described by the guide 
  line.
18. Implementation    Describe anticipated barriers to application of the recommendations. Provide references to any auxiliary documents    
      considerations  for providers or patients that are intended to facilitate implementation. Suggest review criteria for measuring changes   
  in care when the guideline is implemented.
a COGS: Conference on Guideline Standardization.
Evidence-based guideline development.
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Assessment of search sources
The main databases to be used were Medline/PubMed and 
Embase.  The  National  Guidelines  Clearinghouse  and  the 
Guidelines International Network were checked for existing 
guidelines on the subject. Furthermore, the Cochrane Data-
base and the Database of Abstracts of Reviews of Effective-
ness (DARE) were reviewed. With the AGREE instrument 
(Appraisal of Guidelines for Research and Evaluation) devel-
oped for the assessment of clinical practice guidelines, cur-
rent guidelines were evaluated (AGREE Collaboration, 2003). 
Upon the results of this analysis the members of the VTE pre-
vention subgroup decided to use the seventh conference on 
antithrombotic and thrombolytic therapy (ACCP) (2004) as 
a key reference for the new guidelines (Geerts et al. 2004) 
as well as the last Dutch guidelines on the subject. Database 
searches were concentrated from the time that ACCP ended 
until that particular day (2003–2006). When there was doubt 
or possible disagreement with the ACCP on certain issues, an 
extended search was conducted. In the PubMed and Embase 
systematic  searches  with  the  aid  of  the  CBO  employees 
frequently  the  Patient-Intervention-Comparison-Outcome 
(PICO)  method  was  used  (Robinson  and  Dickersin  2002, 
Poolman et al. 2007a). A foreground question narrows down 
the possible answers and is more to the point (Petrisor and 
Bhandari 2006) all four elements were combined and trans-
lated into a database search strategy. Methodological search 
filters proved to be very valuable. The Scottish Intercollegiate 
Guidelines Network (SIGN) provides practical examples of 
these filters (www.sign.ac.uk/guidelines/index.html).
Literature search, assessment selection factors and 
literature selection
The actual searches with relevant search terms resulted alto-
gether in thousands of hits. Selection factors were, for exam-
ple, language (English, German, French, or Dutch), no case 
reports nor letters, meta-analysis, and systematic review. From 
the records selected, abstracts were evaluated. For records that 
were relevant, the corresponding papers were retrieved.
Evaluation of selected literature and evidence table
Assessment of the quality of the literature selected concerned 
the internal validity, where a judgment was made on selec-
tion  bias,  information  bias  and  confounding. Then  an  evi-
dence table was constructed for groups of studies concern-
ing one subject, in which following parameters were scored: 
year of publication, randomization, blinding, set-up, number 
of patients, duration of treatment, lost to follow-up (number, 
reason), outcomes, efficacy, safety, and grading of level of evi-
dence. Grading was done according to Grades of Recommen-
dation Assessment, Development, and Evaluation (GRADE) 
(GRADE Working Group 2004).
Writing and discussion of concept text 
Grading  quality  of  evidence  was  directly  related,  but  only 
one factor when determining the strength of recommenda-
tions (Schunemann et al. 2006b, Akl et al. 2007, Guyatt et al. 
2008a). Each member focused on one or two subjects and was 
supervised by another colleague. In general, the text of each 
topic contained an introduction with an explanation of the 
problem and a summary of the current general literature. Each 
topic was explained, the relevant literature was discussed, and 
other considerations were evaluated (sometimes these were 
non-medical). In the end, a highlighted and boxed recommen-
dation was formulated and graded, again according GRADE 
(Schunemann et al. 2006b, Guyatt et al. 2008a).
A key element of reporting guidelines is the use of a struc-
tured format. Quality of evidence and strength of recommen-
dations should be reported clearly using a standard approach 
(Oxman et al. 2006).
Comments on the guideline from users, and authori-
zation procedure 
The  concept  text  is  now  presented  to  the  various  users. 
Depending  on  the  subject,  it  is  possible  to  invite  selected 
experts to comment, choose a cross-sectional panel, or address 
all users. The Dutch Orthopaedic Association placed the text 
on its website and communicated to all its members that they 
were invited to make comments by e-mail. At the next national 
assembly, the guideline was approved. This authorization is 
a formality where generally content and procedure are not 
discussed but important for its acceptance in clinical practice. 
There is evidence that wide representation of stakeholders in 
guideline panels leads to more balanced recommendations. 
While we have not evaluated this for the example described 
in this article, we believe that the generalization from studies 
to our guideline effort is secure. We achieve this wide repre-
sentation through participation of 23 organizations (250 del-
egates). 
Implementation of a guideline
Strategies of implementation should be tailored to the intended 
users, who are health professionals and their organizations. 
Several models are available for planning and achievement 
of desired improvements, depending on the type of guide-
line. Dissemination of the guideline plays a key role in its 
implementation (Fretheim et al. 2006a). The distribution of 
the authorized text to the users through a mailing from the 
various associations and to the hospitals and its administra-
tors and publication in peer reviewed journals and websites, 
are essential. Also, patient information and flow charts can be 
valuable. Shiffman and co-workers developed and validated 
a tool to help in guideline implementation: “The Guideline 
Implementability Appraisal” (GLIA) (Shiffman et al. 2005).
In order to determine quality in healthcare, there is a need 
for  indicators.  Evidence-based  guidelines  are  particularly 
suited  to  development  of  indicators.  The  requirements  for 
these indicators are:
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2.  Related to patientcare
3.  Result(s) in improvement
4.  Sufficiently specific and sensitive
5.  Readily available
6.  Wide applicability
7.  Relevant to society
8.  Strong recommendations, or documentation that a deci-
sion-making process has taken place for weak recom-
mendations.
The evaluation of the last 1999 Dutch guideline of the sec-
tion prevention VTE orthopedic surgery was evaluated through 
a questionnaire send to all orthopedics departments (Ettema et 
al. 2005). This is an appraisal of external indicators. In the 
case of a procedure such as a hip or knee arthroplasty, the use 
of a specific kind of pharmacological thromboprophylaxis is 
a process indicator and the incidence of VTE (according to a 
strict definition) is an outcome indicator. 
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